Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon

This publication has 14 references indexed in Scilit:

• RECOMBINANT α2-INTERFERON TREATMENT IN CHILDREN WITH CHRONIC HEPATITIS B
  The Lancet, 1988
• Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
  Cancer, 1987
• Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection
  Journal of Hepatology, 1987
• The detection of antibodies to recombinant interferon alfa-2a in human serum
  Journal of Biological Standardization, 1987
• Safety and tolerance of recombinant interferon alfa-2a (roferon®-A) in Cancer Patients
  Cancer, 1986
• Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)
  The American Journal of Medicine, 1986
• Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients
  Annals of Internal Medicine, 1982
• The detection of hbv‐dna in serum by molecular hybridisation: A more sensitive method for the detection of complete hbv particles
  Journal of Medical Virology, 1982
• Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled study
  Gastroenterology, 1981
• Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon
  Nature, 1981